Cutaneous manifestations of dabrafenib (GSK2118436): a selective inhibitor of mutant BRAF in patients with metastatic melanoma (Q38026916)
scientific article published on 05 October 2012
Language:
(P31) (Q13442814)
(P50) (Q28868730)
(Q42947998)
(Q54286183)
(P304) 1153-1160
(P407) (Q1860)
(P433) 5
(P478) 167
(P577) Friday, October 5, 2012
(P921) (Q18975855)
(P1433) (Q4970191)
(P1476) "Cutaneous manifestations of dabrafenib (GSK2118436): a selective inhibitor of mutant BRAF in patients with metastatic melanoma" (language: en)
(P2093) R M Anforth
T C M P Blumetti
R F Kefford
R Sharma
S Kossard
(P2860) (Q37568972)
(Q37280728)
(Q29614803)
(Q37493375)
(Q54610975)
(Q24631953)
(Q27860458)
(Q27851801)
(Q51770070)
(Q42485961)
(Q46857527)
(Q46542862)
(Q50518821)
(Q27659493)
(Q24298749)
(Q29616828)
(Q35721081)
(Q37048053)
(Q42527823)
(Q37150943)
(Q42529002)
(Q58024796)
(Q58024790)
(Q58024751)
other details
description scientific article published on 05 October 2012

External Links